History of Medicine PhD student at Université de Strasbourg. Studying the history of antibiotic development, AMR, and TB since 1980. Searching for a postdoc!
@UnionConference-2025 has started in Copenhagen!
The conference was opened by Dr Hans Kluge, Director of the WHO Regional Office for Europe.
From 18 to 21 November, the TBEC representatives are going to actively participate in the conference.
Henry Reider, an inspiring survivor of tuberculosis speaks at the opening of the world conference on lung health and tuberculosis.
Let’s end tuberculosis and lung disease!
@johngreen
Currently at #WCLH2025#UnionConf representing the University of Vienna and the #ALTERBIOTIC project. It has been a very full day with lots of engaged stakeholders and participants.
#TB#GlobalHealth
Just sent in my thesis for final feedback and comments. Jury in the process of being selected. The light at the end of the PhD tunnel is starting to get brighter!
The #antibiotics pipeline is "on the verge of collapse," due to developers struggling to stay in business in the current financial market, according to @koutterson, executive director of @CARB_X. More in @ghn_news: https://t.co/qCvGBXJvTl
Professor Alison Holmes, Director of the Fleming Initiative, had a packed #WorldAMRAwarenessWeek sharing our vision for fighting antimicrobial resistance across the globe ⤵️
https://t.co/5JQOSKAGH7
November is a crucial month for raising awareness about #AMR.
Join us today for European Antibiotic Awareness Day (@EAAD_EU), kicking off World AMR Awareness Week (18-24 November).
Check out our #UnderstandingAMR campaign: https://t.co/hki9WgZlyc
#antibiotics#PatientAdvocacy
Over 400,000 people develop MDR/RR-TB each year, yet only 44% were diagnosed and treated in 2023. This WorldvAntimicrobialvResistance Awareness Week, we call on leaders to uphold their promises in the AMR Declaration and support #DRTB treatment worldwide. #WAAV#EndTB
Antimicrobial resistance is one of the greatest global health challenges we face and without action 39m lives could be lost by 2050. Through innovation, collaboration & a #OneHealth approach we can change the future #WAAW2024#AMR#EducateAdvocateAct@FlemingFund
A new study in @Nature found that rifaximin, an antibiotic commonly used to treat liver disease, causes resistance to daptomycin. https://t.co/z15wO6PDYD via @guardian#AMR
Our charity has recently started a YouTube channel and we need your support to grow!
Subscribe to our channel here: https://t.co/PiZ2Ytjt8p
#theAMRnarrative#AMR#AntimicrobialResistance
On Sept 19, 2024, WHO Director-General @DrTedros warned that the AMR crisis urgently requires a “well-coordinated global response”.
The Global Antibiotic Research and Development Partnership (GARDP) is a key part of that response.
Find out more: https://t.co/yX4933UHY8
"It will be crucial to keep #AMR embedded in global discussions on pandemic preparedness, align financing with public health needs and prioritize access to essential #antibiotics for all," new @WHO and @GlobalAMRHub report finds. https://t.co/O9zdgvgJGY
Our research team sat down with members of the health community to discuss how PPPs became involved in developing new #antibiotics to fight #AMR. Read the complete transcript of our witness seminar here: https://t.co/Agy3Qyt9jg (open access!!)
Launched! @USAID and #StopTB Partnership launch the “Governance of TB Programmes Report”
You can access the full report here: https://t.co/6n7T4t20FK
#YesWeCanEndTB#EndTB